Effect of autoimmune diseases on risk and survival in histology-specific lung cancer

European Respiratory Journal

Volumn 40, Issue 6, 2012, Pages 1489-1495

  Hemminki, Kari ^a,b   Liu, X ^b   Ji, Jianguang ^b   Sundquist, Jan ^a,c   Sundquist, Kristina ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbidity; Immune disturbance; Prognosis; Risk; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COMORBIDITY; DERMATOMYOSITIS; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; HAZARD RATIO; HOSPITALIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATIC FEVER; SMALL CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO; STANDARDIZED MORTALITY RATIO; SWEDEN; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; CARCINOMA, SMALL CELL; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK; SWEDEN; TREATMENT OUTCOME;

EID: 84867683493     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00222911     Document Type: Article

References (41)

1. Forabosco P, Bouzigon E, Ng MY, et al. Meta-analysis of genomewide linkage studies across autoimmune diseases. Eur J Hum Genet 2009; 17: 236-243.
2. Zhernakova A, van Diemen CC, Wijmenga C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat Rev Genet 2009; 10: 43-55.
3. Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer 2009; 124: 1497-1502.
4. Brown LM, Gridley G, Check D, et al. Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders. Blood 2008; 111: 3388-3394.
5. Landgren AM, Landgren O, Gridley G, et al. Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer 2011; 117: 1163-1171.
6. Hemminki K, Liu X, Ji J, et al. Autoimmune disease and subsequent digestive tract cancer by histology. Ann Oncol 2012; 23: 927-933.
7. Vajdic CM, van Leeuwen MT. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 2009; 125: 1747-1754.
8. Rayner CF, Grubnic S. Pulmonary manifestations of systemic autoimmune disease. Best Pract Res Clin Rheumatol 2004; 18: 381-410. (Pubitemid 38950059)
9. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006; 18: 129-134. (Pubitemid 43740384)
10. Gayed M, Bernatsky S, Ramsey-Goldman R, et al. Lupus and cancer. Lupus 2009; 18: 479-485.
11. Hemminki K, Li X, Sundquist K, et al. Cancer risk in hospitalized rheumatoid arthritis patients. Rheumatology (Oxford) 2008; 47: 698-701. (Pubitemid 351619215)
12. Hemminki K, Li X, Sundquist J, et al. Cancer risks in Crohn disease patients. Ann Oncol 2009; 20: 574-580.
13. Ji J, Shu X, Sundquist K, et al. Cancer risk in hospitalised psoriasis patients: a follow-up study in Sweden. Br J Cancer 2009; 100: 1499-1502.
14. Ji J, Shu X, Li X, et al. Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 2009; 20: 1121-1126.
15. Hemminki K, Li X, Sundquist J, et al. Cancer risks in ulcerative colitis patients. Int J Cancer 2008; 123: 1417-1421.
16. Shu X, Ji J, Sundquist K, et al. Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964-2006. Ann Oncol 2011; 22: 1427-1434.
17. Shu X, Ji J, Sundquist J, et al. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis 2011; 17: 816-822.
18. Ji J, Liu X, Sundquist K, et al. Survival of cancer in patients with rheumatoid arthritis: a follow-up study in Sweden of patients hospitalized with rheumatoid arthritis 1 year before diagnosis of cancer. Rheumatology (Oxford) 2011; 50: 1513-1518.
19. Shu X, Ji J, Sundquist J, et al. Survival in cancer patients hospitalized for psoriasis: a population-based cohort study in Sweden. Br J Dermatol 2011; 165: 129-136.
20. Hemminki K, Liu X, Ji J, et al. Effect of autoimmune diseases on mortality and survival in subsequent digestive tract cancers. Ann Oncol 2012; 23: 2179-2184.
21. Hemminki K, Liu X, Ji J, et al. Effect of autoimmune diseases on risk and survival in female cancers. Gynecol Oncol 2012; 127: 180-185.
22. Hemminki K, Li X, Sundquist K, et al. Familial risks for chronic obstructive pulmonary disease among siblings based on hospitalizations in Sweden. J Epidemiol Community Health 2008; 62: 398-401. (Pubitemid 351579912)
23. Hemminki K, Li X, Sundquist K, et al. Familial risks for asthma among twins and other siblings based on hospitalizations in Sweden. Clin Exp Allergy 2007; 37: 1320-1325. (Pubitemid 47372283)
24. Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450.
25. Hemminki K, Li X, Sundquist J, et al. Familial associations of rheumatoid arthritis with autoimmune disorders and related conditions. Arthritis Rheum 2009; 60: 661-668.
26. Hemminki K, Li X, Sundquist J, et al. Familial association between type 1 diabetes and other autoimmune and related diseases. Diabetologia 2009; 52: 1820-1828.
27. Hemminki K, Li X, Sundquist J, et al. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution. J Autoimmun 2010; 34: J307-J313.
28. Hemminki K, Li X, Sundquist K, et al. Familial association of inflammatory bowel diseases with other autoimmune and related diseases. Am J Gastroenterol 2010; 105: 139-147.
29. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 2006; 15: 737-745.
30. Lorenzo Bermejo J, Hemminki K. Familial lung cancer and aggregation of smoking habits: a simulation of the effect of shared environmental factors on the familial risk of cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1738-1740. (Pubitemid 40995088)
31. Center for Epidemiology. Cancer Incidence in Sweden 2009. Stockholm, The National Board of Health and Welfare, 2010.
32. Belani CP, Marts S, Schiller J, et al. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer 2007; 55: 15-23. (Pubitemid 46038875)
33. ParsonsA,DaleyA, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ 2010; 340: b5569.
34. Olesen AB, Svaerke C, Farkas DK, et al. Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 2010; 163: 800-806.
35. Sartor R. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nature Clin Pract Gastroenterol Hepatol 2006; 3: 390-407. (Pubitemid 44018812)
36. Schreiber S, Rosenstiel P, Albrecht M, et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005; 6: 376-388. (Pubitemid 40577181)
37. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
38. Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology 2010; 138: 2101-2114 e5.
39. Rothwell PM, Fowkes FG, Belch JF, et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31-41.
40. Citterio A, Beghi E, Millul A, et al. Risk factors for tumor occurrence in patients with myasthenia gravis. J Neurol 2009; 256: 1221-1227.
41. Tsinzerling N, Lefvert AK, Matell G, et al. Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 2007; 78: 1109-1112.